Brad E. Windle

949 total citations
12 papers, 349 citations indexed

About

Brad E. Windle is a scholar working on Oncology, Molecular Biology and Biotechnology. According to data from OpenAlex, Brad E. Windle has authored 12 papers receiving a total of 349 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 3 papers in Biotechnology. Recurrent topics in Brad E. Windle's work include Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (3 papers) and Machine Learning in Bioinformatics (2 papers). Brad E. Windle is often cited by papers focused on Cancer-related Molecular Pathways (7 papers), Cancer Research and Treatments (3 papers) and Machine Learning in Bioinformatics (2 papers). Brad E. Windle collaborates with scholars based in United States, Finland and China. Brad E. Windle's co-authors include Sumitra Deb, Swati Palit Deb, Catherine A. Vaughan, W. Andrew Yeudall, Shilpa Singh, Iain M. Morgan, Tara J. Nulton, Hiroshi Miyazaki, Hui‐Xin Wang and Anna Bulysheva and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Biochemical and Biophysical Research Communications.

In The Last Decade

Brad E. Windle

12 papers receiving 347 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brad E. Windle United States 10 213 206 82 62 50 12 349
Daniel Garcia United States 6 276 1.3× 160 0.8× 72 0.9× 35 0.6× 37 0.7× 6 406
Yan Stein Israel 9 200 0.9× 160 0.8× 84 1.0× 55 0.9× 34 0.7× 12 353
Mallika Ramakrishnan Germany 8 134 0.6× 134 0.7× 79 1.0× 53 0.9× 25 0.5× 8 299
Phillip H. Koeffler United States 6 336 1.6× 205 1.0× 56 0.7× 58 0.9× 45 0.9× 13 467
Suzanne Camus United Kingdom 10 370 1.7× 206 1.0× 78 1.0× 46 0.7× 32 0.6× 10 470
Naishitha Anaparthy United States 5 168 0.8× 138 0.7× 83 1.0× 35 0.6× 20 0.4× 6 321
Christopher M. Hoffmann Germany 8 228 1.1× 313 1.5× 129 1.6× 26 0.4× 45 0.9× 15 456
Nadia Naski France 7 391 1.8× 254 1.2× 112 1.4× 41 0.7× 33 0.7× 7 499
Bin Kan China 9 230 1.1× 103 0.5× 56 0.7× 55 0.9× 34 0.7× 13 370
Guilherme Francisco Brazil 10 210 1.0× 108 0.5× 94 1.1× 34 0.5× 15 0.3× 13 294

Countries citing papers authored by Brad E. Windle

Since Specialization
Citations

This map shows the geographic impact of Brad E. Windle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brad E. Windle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brad E. Windle more than expected).

Fields of papers citing papers by Brad E. Windle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brad E. Windle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brad E. Windle. The network helps show where Brad E. Windle may publish in the future.

Co-authorship network of co-authors of Brad E. Windle

This figure shows the co-authorship network connecting the top 25 collaborators of Brad E. Windle. A scholar is included among the top collaborators of Brad E. Windle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brad E. Windle. Brad E. Windle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
James, Claire D., Fatmata Sesay, Audra N. Iness, et al.. (2021). Restoring the DREAM Complex Inhibits the Proliferation of High-Risk HPV Positive Human Cells. Cancers. 13(3). 489–489. 12 indexed citations
2.
Vaughan, Catherine A., Shilpa Singh, Mark A. Subler, et al.. (2021). The oncogenicity of tumor-derived mutant p53 is enhanced by the recruitment of PLK3. Nature Communications. 12(1). 704–704. 18 indexed citations
3.
Grace, Miranda, Tara J. Nulton, Brad E. Windle, et al.. (2019). PTPN14 degradation by high-risk human papillomavirus E7 limits keratinocyte differentiation and contributes to HPV-mediated oncogenesis. Proceedings of the National Academy of Sciences. 116(14). 7033–7042. 79 indexed citations
4.
Cai, Jinyang, Ming Sun, Bin Hu, et al.. (2019). Sorting Nexin 5 Controls Head and Neck Squamous Cell Carcinoma Progression by Modulating FBW7. Journal of Cancer. 10(13). 2942–2952. 15 indexed citations
5.
Vaughan, Catherine A., Shilpa Singh, Steven R. Grossman, et al.. (2017). Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells. Molecular Oncology. 11(6). 696–711. 14 indexed citations
6.
Vaughan, Catherine A., Isabella Pearsall, Shilpa Singh, et al.. (2016). Addiction of lung cancer cells to GOF p53 is promoted by up-regulation of epidermal growth factor receptor through multiple contacts with p53 transactivation domain and promoter. Oncotarget. 7(11). 12426–12446. 17 indexed citations
7.
Vaughan, Catherine A., Swati Palit Deb, Sumitra Deb, & Brad E. Windle. (2014). Preferred binding of gain-of-function mutant p53 to bidirectional promoters with coordinated binding of ETS1 and GABPA to multiple binding sites. Oncotarget. 5(2). 417–427. 12 indexed citations
8.
Vaughan, Catherine A., Isabella Pearsall, Shilpa Singh, et al.. (2012). Allele specific gain-of-function activity of p53 mutants in lung cancer cells. Biochemical and Biophysical Research Communications. 428(1). 6–10. 20 indexed citations
9.
Ko, Daijin & Brad E. Windle. (2011). Enriching for correct prediction of biological processes using a combination of diverse classifiers. BMC Bioinformatics. 12(1). 189–189. 5 indexed citations
10.
Yeudall, W. Andrew, Catherine A. Vaughan, Hiroshi Miyazaki, et al.. (2011). Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration. Carcinogenesis. 33(2). 442–451. 103 indexed citations
11.
Vaughan, Catherine A., Shilpa Singh, Brad E. Windle, et al.. (2011). p53 mutants induce transcription of NF-κB2 in H1299 cells through CBP and STAT binding on the NF-κB2 promoter and gain of function activity. Archives of Biochemistry and Biophysics. 518(1). 79–88. 49 indexed citations
12.
Ko, Daijin, Wanyan Xu, & Brad E. Windle. (2005). Gene function classification using NCI-60 cell line gene expression profiles. Computational Biology and Chemistry. 29(6). 412–419. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026